Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone

Completed

• Conditions: Ocular Melanoma; Choroidal Melanoma; Uveal Melanoma

• Registration Number: NCT00351728
• Lead Sponsor: Jonsson Comprehensive Cancer Center

Brief Summary

Patients diagnosed with ocular melanoma consent to participate in the study. Combined PET/CT scans of the whole body are performed at baseline, three months later, and six months after that for a total of three combined scans in the first year. Subsequently, these combined scans will be performed at 6-monthly intervals for a total of two combined scans per year.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-06
• Study First Submitted: 2006-07-12
• Study First Submitted QC: 2006-07-12
• Study First Posted: 2006-07-13
• Primary Completion: 2012-08
• Study Completion: 2012-08
• Status Verified: 2016-07
• Last Update Submitted: 2016-07-05
• Last Update Posted: 2016-07-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 174

Inclusion Criteria

1. Patients with a diagnosis of ocular melanoma (a pigmented malignant tumor) involving the choroid and/or ciliary body (the blood vessel layer in the back of the eye and/or the part of the eye behind the iris).
2. Patients 18 years of age or older.
3. Patients able to give informed consent.

Exclusion Criteria

1. Patients who refuse to participate in the study.
2. Patients who are unable to cooperate with or cannot undergo PET/CT scanning.
3. Patients who will be moving out of the area of UCLA during the ten years of this study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Jules Stein Eye Institute; 🇺🇸 Los Angeles, California, United States